Evoqua Water Technologies, an industry leader in mission-critical water treatment solutions, today announced the closing of the previously announced acquisition of the renal business historically operated by Mar Cor Purification and Cantel Medical, subsidiaries of STERIS Plc.
Mar Cor is a leading manufacturer and servicer of medical water, commercial and industrial solutions in North America. Headquartered in Plymouth, Minnesota, Mar Cor has 27 service and regeneration facilities in the United States and Canada. Mar Cor offers significant technical expertise in designing, building, and servicing high-purity water treatment systems to an installed base of approximately 5,500 sites.
The business is expected to generate annualized revenues of approximately $180 million and adjusted EBITDA of approximately $27 million before synergies. The addition of the business will expand Evoqua’s service footprint in North America, furthering its reach into the healthcare vertical market.
“We are thrilled to officially welcome Mar Cor to the Evoqua family,” said Ron Keating, Evoqua’s Chief Executive Officer. “With the close of this transaction, Evoqua is well-positioned to expand our service footprint in North America to provide proven water solutions for the healthcare industry.”
Read more Evoqua Water Technologies Articles and News on H2O Global News. Do you have an article or video that you would like to share? Submit your article here or keep up with the latest news from the water industry and wastewater industry by subscribing to our weekly newsletter
